[
  {
    "text": "JEFFREY MARK DRAZEN: So this\nis how I view pharmacogenomics. It's the use of\ngenetic information to determine who will respond\nfavorably or unfavorably.",
    "start": "0",
    "end": "8038"
  },
  {
    "text": "And I think,\nactually, unfavorably may be a better phenotype to\na given type of treatment.",
    "start": "8039",
    "end": "14440"
  },
  {
    "text": "And the reason I say that is\nthat, especially the condition that I study, asthma,\nthere are a lot",
    "start": "14440",
    "end": "20759"
  },
  {
    "text": "of folks that have a placebo\neffect from treatment.",
    "start": "20760",
    "end": "27220"
  },
  {
    "text": "And so if I'm studying a\ndrug and I give everybody a placebo-- that's my trial. I compare placebo A to the pink\nplacebo, to the yellow placebo.",
    "start": "27220",
    "end": "35670"
  },
  {
    "text": "And I know this is\njust a sugar pill and shouldn't have any\nbiological impact on asthma.",
    "start": "35670",
    "end": "42070"
  },
  {
    "text": "But I know that\n25% of people are going to get better from this.",
    "start": "42070",
    "end": "48040"
  },
  {
    "text": "And if I'm stratifying\nmy outcome by genotypes,",
    "start": "48040",
    "end": "53490"
  },
  {
    "text": "you'll see that I\ncould be misled. But if I'm looking\nfor a phenotype",
    "start": "53490",
    "end": "59199"
  },
  {
    "text": "which is less likely to be\ncontaminated by a placebo effect-- for example, people who\nget worse with treatment--",
    "start": "59200",
    "end": "69588"
  },
  {
    "text": "then I'm looking at the\nnatural history of the disease. And I'm less likely to\nbe confounded by that.",
    "start": "69588",
    "end": "76200"
  },
  {
    "text": "Now if you're studying\nsomething like cancer or heart disease with a hard end\npoint, which is death--",
    "start": "76200",
    "end": "83520"
  },
  {
    "text": "heart disease with a soft end\npoint, which is chest pain-- it's hard to know. But heart disease with\nthe heart end point,",
    "start": "83520",
    "end": "89572"
  },
  {
    "text": "something that's\neasy to define, you don't have this big a problem. And you can begin to use\nfavorable and unfavorable",
    "start": "89572",
    "end": "95880"
  },
  {
    "text": "responses. So I think it's a little\nmore robust phenotype. What it means is that\nwhenever I do a study,",
    "start": "95880",
    "end": "102150"
  },
  {
    "text": "I have to think about the\ncontaminating effect of this. Looking at my data. I know that some\nof the people whom",
    "start": "102150",
    "end": "108210"
  },
  {
    "text": "I think are better because of\ntreatment or, in this case, because of a treatment\nby genotype interaction",
    "start": "108210",
    "end": "114780"
  },
  {
    "text": "are just better by\nchance, and that there are more likely to\nbe people better by chance in the placebo\ngroup than there would",
    "start": "114780",
    "end": "122549"
  },
  {
    "text": "be if there was a no\ntreatment group, just because of the nature\nof that effect. So it's a little bit\nof a contamination",
    "start": "122550",
    "end": "128340"
  },
  {
    "text": "but not a big problem. So the idea of pharmacogenetics\nis that there's variability",
    "start": "128340",
    "end": "134130"
  },
  {
    "text": "in treatment response. So if I treat a\nbunch of people-- that some people are\ngoing to get better.",
    "start": "134130",
    "end": "140485"
  },
  {
    "text": "Some people are going\nto stay the same. Some people can\nget a little worse. Since we don't think the\nmedicine makes them worse,",
    "start": "140485",
    "end": "146040"
  },
  {
    "text": "usually we think that\nit's the disease getting worse because the\nmedicine is ineffective.",
    "start": "146040",
    "end": "152380"
  },
  {
    "text": "So the first thing\nthat you want to do if you want to study the\npharmacogenetics of anything,",
    "start": "152380",
    "end": "159120"
  },
  {
    "text": "you want to look to see\nhow variable the treatment response is among\nmembers of a population.",
    "start": "159120",
    "end": "165549"
  },
  {
    "text": "And there needs to be\nsubstantial variance in treatment response among\nmembers of a population. So I'm going to give you an\nexample now, from the asthma",
    "start": "165550",
    "end": "172980"
  },
  {
    "text": "world, of a study in which there\nwas variation in the treatment",
    "start": "172980",
    "end": "178290"
  },
  {
    "text": "response among members\nof a population. So this is a clinical trial.",
    "start": "178290",
    "end": "183300"
  },
  {
    "text": "It's easy to understand. Here are patients\nthat are enrolled with mild to moderate asthma.",
    "start": "183300",
    "end": "189690"
  },
  {
    "text": "And this is asthma which\nis more of a nuisance than a real medical problem. So if patients are\nnot treated, it",
    "start": "189690",
    "end": "196320"
  },
  {
    "text": "doesn't represent\nan ethical issue. So that's how we can get away\nwith a two-week placebo run, in theory, because it's\nOK not to treat people.",
    "start": "196320",
    "end": "205710"
  },
  {
    "text": "And are then randomized to\nreceive beclomethasone, which is an inhaled steroid and is\none of the standard asthma",
    "start": "205710",
    "end": "211680"
  },
  {
    "text": "treatments compared\nto montelukast, which is an antagonist to the action\nof the cysteinyl leukotrienes",
    "start": "211680",
    "end": "218980"
  },
  {
    "text": "at the CysLT1 receptor. And the primary outcome\nin this and a lot of the data I'm\ngoing to show you",
    "start": "218980",
    "end": "224760"
  },
  {
    "text": "is the forced expiratory volume\nin one second to 12 weeks. So as an aside by way\nof pulmonary physiology,",
    "start": "224760",
    "end": "232140"
  },
  {
    "text": "I don't think we\nrecognize any of you from suggestive pulmonary class.",
    "start": "232140",
    "end": "238319"
  },
  {
    "text": "No, none of you are taking that. If you breathe in all\nthe way to the top and then breathe out as hard\nand fast as you possibly can--",
    "start": "238320",
    "end": "245459"
  },
  {
    "text": "something like you might\ngo on your birthday. If you have a lot of\ncandles to blow out-- how fast you can breathe\nout beyond a certain level",
    "start": "245460",
    "end": "252810"
  },
  {
    "text": "of effort is an\nintrinsic property of your lungs and airways and\nnot how hard you're trying.",
    "start": "252810",
    "end": "260100"
  },
  {
    "text": "So you have to try hard\nenough to reach that plateau. And that is not a\nsuperhuman effort. Almost everybody with\na little bit of effort",
    "start": "260100",
    "end": "267120"
  },
  {
    "text": "can reach that level where\nhow fast they can breathe out",
    "start": "267120",
    "end": "272430"
  },
  {
    "text": "is not related to how hard\nthey're trying to breathe. So that if we measure the amount\nof air that comes out in one",
    "start": "272430",
    "end": "279180"
  },
  {
    "text": "second , we're measuring an\nintrinsic property in the lungs and not the motivation\nof the subject.",
    "start": "279180",
    "end": "284449"
  },
  {
    "text": "And it's beyond a\ncertain level of effort. And the way you determine\nwhether your subjects are motivated is usually do\ntwo or three maneuvers.",
    "start": "284450",
    "end": "292100"
  },
  {
    "text": "We have somebody\ncoaching them through it. Deep breath in and out. Blast it out so you get to\nsee whether they're actually trying.",
    "start": "292100",
    "end": "297990"
  },
  {
    "text": "And if this test\nis done correctly, the variability among tests\ndone in a row is 3% or 4%,",
    "start": "297990",
    "end": "306620"
  },
  {
    "text": "even among you all who've never\nprobably done this test before. Maybe one of you have asthma. Statistics would be that one or\ntwo of you would have asthma,",
    "start": "306620",
    "end": "313639"
  },
  {
    "text": "have done tests like this. Without any coaching or\nwith minimal coaching, can get tested and reproducible\nwithin 3% or 4% off the street.",
    "start": "313640",
    "end": "322400"
  },
  {
    "text": "So it's a very useful test\nbecause it's easy to do. And we use it as an\noutcome indicator",
    "start": "322400",
    "end": "327979"
  },
  {
    "text": "in a lot of breathing trials. And just to help\nget you straight. A bigger FEV1, the more air\nyou can get out in one second,",
    "start": "327980",
    "end": "334400"
  },
  {
    "text": "the better off are. So that's kind of this\noutcome indicator. So here are the data.",
    "start": "334400",
    "end": "341720"
  },
  {
    "text": "And this is the trial outcome. This is what was\npublished in this journal. And you can see that\nthe patients assigned",
    "start": "341720",
    "end": "348170"
  },
  {
    "text": "to the beclomethasone\narm improved their FEV1 about 11% to 13% on average.",
    "start": "348170",
    "end": "354770"
  },
  {
    "text": "While the people in\nthe montelukast group improve it 7% to 9%. Now we know from studies\ndone in patients with asthma",
    "start": "354770",
    "end": "361880"
  },
  {
    "text": "that if you improve\nyour FEV1 about 10%, that you can perceive it.",
    "start": "361880",
    "end": "367040"
  },
  {
    "text": "It's something\nthat you say, hey, I'm better from\nwhatever you just did.",
    "start": "367040",
    "end": "372980"
  },
  {
    "text": "Below that, it's\nhard to distinguish. Above that, if you\nimprove it twice as much,",
    "start": "372980",
    "end": "378790"
  },
  {
    "text": "you really don't\ndistinguish it that much, unless you happen to be engaging\nin really heavy exercise.",
    "start": "378790",
    "end": "384470"
  },
  {
    "text": "So it's almost a\ndichotomous kind of variable, people\nwho got better, people who didn't get better. You'd look at these\ndata and you'd say,",
    "start": "384470",
    "end": "390500"
  },
  {
    "text": "gee, it looks like\nbeclomethasone is almost twice as good as montelukast. So here are the data now\nshown in histogram format",
    "start": "390500",
    "end": "400729"
  },
  {
    "text": "where on the vertical\naxis, we have the percentage of patients. And on the horizontal axis,\nwe have changes in FEV1.",
    "start": "400730",
    "end": "407870"
  },
  {
    "text": "So the patients that\nwill be over on this end had a big response.",
    "start": "407870",
    "end": "413240"
  },
  {
    "text": "Patients over here actually\ngot worse with treatment. And the null is\nright in the middle.",
    "start": "413240",
    "end": "418290"
  },
  {
    "text": "And this 10% to 20% bar,\nanything over this direction,",
    "start": "418290",
    "end": "423950"
  },
  {
    "text": "is an improvement. I don't know how to\nget that to go away. Usually these little boxes go\naway if you leave them alone",
    "start": "423950",
    "end": "431060"
  },
  {
    "text": "long enough. ",
    "start": "431060",
    "end": "436280"
  },
  {
    "text": "Let's see if I do it again. No, cancel.",
    "start": "436280",
    "end": "441370"
  },
  {
    "text": "So here we are with montelukast. And you see that there\nwere about, altogether, 5% of the population\nwho really did great.",
    "start": "441370",
    "end": "448500"
  },
  {
    "text": "There were about 7%\nof the population that actually got a lot worse. And that it turns out\nthat it's about 42%",
    "start": "448500",
    "end": "456030"
  },
  {
    "text": "of the population that\nimproved a significant amount. ",
    "start": "456030",
    "end": "461159"
  },
  {
    "text": "Now compare this\nto beclomethasone, which, remember, on\naverage, did twice as well.",
    "start": "461160",
    "end": "466330"
  },
  {
    "text": "Well, here's the difference. There were twice as many people\nthat did spectacularly well.",
    "start": "466330",
    "end": "471900"
  },
  {
    "text": "But on the average not a lot. It works out to be\n10% versus 5% in some.",
    "start": "471900",
    "end": "479070"
  },
  {
    "text": "And rather than having 7%\nof people who did poorly, it was just 4%.",
    "start": "479070",
    "end": "484300"
  },
  {
    "text": "So it turns out that\nif you trim these by getting-- like they do\nsometimes in the Olympics. They get rid of your best\nand your worst scores.",
    "start": "484300",
    "end": "492160"
  },
  {
    "text": "If you trim this in\nthat end, the groups are almost identical. And so the difference\nin the means",
    "start": "492160",
    "end": "499710"
  },
  {
    "text": "reflects poorly on actually\nwhat the difference would be in the population.",
    "start": "499710",
    "end": "505318"
  },
  {
    "text": "Because if you're a patient\nsitting in my waiting room and your FEV1\none's improved by 60%",
    "start": "505318",
    "end": "510581"
  },
  {
    "text": "and you're sitting\nnext to somebody whose FEV1's improved 0%, the\naverage improvement between you",
    "start": "510581",
    "end": "515909"
  },
  {
    "text": "is 30%. But both of you\ndidn't get better, even though the inference would\nbe that you are [INAUDIBLE]",
    "start": "515909",
    "end": "521539"
  },
  {
    "text": "better. So here we see a big population\nvariability in response to montelukast and inhibitor\nof the actions of leukotrienes",
    "start": "521539",
    "end": "528690"
  },
  {
    "text": "and leukotriene receptor\nin beclomethasone. So I'm going to explore\nthe basis of these two",
    "start": "528690",
    "end": "534540"
  },
  {
    "text": "and, depending on time, one\nmore treatment in asthma.",
    "start": "534540",
    "end": "540000"
  },
  {
    "text": "And there's big\npopulation variability. And the second thing\nthat you need to know--",
    "start": "540000",
    "end": "545220"
  },
  {
    "text": "before I get to this, which\nI didn't bring you the data to show--",
    "start": "545220",
    "end": "551901"
  },
  {
    "text": "if I study you once,\nand you're over here, and I'm looking at a genetic\nevent, that is something",
    "start": "551901",
    "end": "558270"
  },
  {
    "text": "that you inherited,\nwhenever I study you, you ought to get it\nbetter with this medicine.",
    "start": "558270",
    "end": "565649"
  },
  {
    "text": "Because if it's a\ngenetic event, it ought to be something\nthat is imprinted on you and stay that way.",
    "start": "565650",
    "end": "570870"
  },
  {
    "text": "While if it's variable\nfrom time to time, then it's not\ngoing to be useful.",
    "start": "570870",
    "end": "576250"
  },
  {
    "text": "So you need to\nknow how repeatable the treatment response is.",
    "start": "576250",
    "end": "583170"
  },
  {
    "text": "If the basis of the\nvariance is genetic, it ought to be\nhighly repeatable.",
    "start": "583170",
    "end": "589500"
  },
  {
    "text": "While if it's due to random\nnoise like the reason you improved so\nmuch here was that",
    "start": "589500",
    "end": "596490"
  },
  {
    "text": "during the two-week\nrunning period, you'd spent time with your\nmother-in-law who has six cats. And you're allergic to cats.",
    "start": "596490",
    "end": "602970"
  },
  {
    "text": "So your lung function was\nlow before you started. You then got better during\nthe treatment period",
    "start": "602970",
    "end": "609480"
  },
  {
    "text": "because you got\naway from the cats. If I then restudied\nyou, you wouldn't get this kind of response.",
    "start": "609480",
    "end": "615660"
  },
  {
    "text": "AUDIENCE: [INAUDIBLE] JEFFREY MARK DRAZEN:\nWell, so actually I",
    "start": "615660",
    "end": "621839"
  },
  {
    "text": "can show you those\ndata, depending on how much time we have. I'll show it to you right now. It's out of the\ncontext of this talk.",
    "start": "621840",
    "end": "627317"
  },
  {
    "text": "Just pardon me one second. I'll see if I can find-- I have these data\nactually in another talk.",
    "start": "627317",
    "end": "634514"
  },
  {
    "start": "634515",
    "end": "639538"
  },
  {
    "text": "No, no, it won't take too long. Hopefully, it won't take\nyou long to find it. could Let's see. ",
    "start": "639538",
    "end": "653070"
  },
  {
    "text": "No, it's not that one. ",
    "start": "653070",
    "end": "658830"
  },
  {
    "text": "I'll give it one more try here. Just look in a different place. ",
    "start": "658830",
    "end": "678020"
  },
  {
    "text": "I think it's here. ",
    "start": "678020",
    "end": "688960"
  },
  {
    "text": "No. One more try. Thought it was there. ",
    "start": "688960",
    "end": "705225"
  },
  {
    "text": "The nice thing about\nhaving a big hard drive, you can carry all\nsorts of stuff around. ",
    "start": "705225",
    "end": "713250"
  },
  {
    "text": "See if it's in this one. ",
    "start": "713250",
    "end": "718560"
  },
  {
    "text": "Yeah, here they are. OK, so here data from a trial.",
    "start": "718560",
    "end": "725430"
  },
  {
    "text": "And I was lucky. Because this is\na different drug. But this acts like a\n5-lipoxygenase pathway.",
    "start": "725430",
    "end": "731130"
  },
  {
    "text": "And the drug company that I\nworked with gave me the data. They sent it to me on a CD.",
    "start": "731130",
    "end": "737134"
  },
  {
    "text": "And a lot of drug\ncompanies won't do that because they're\nafraid that you're going to do something that\nwill hurt them with respect",
    "start": "737135",
    "end": "743130"
  },
  {
    "text": "to their market position. They tend to be really paranoid. So to get on this graph, you\nhad to improve your FEV1 by 12%.",
    "start": "743130",
    "end": "752760"
  },
  {
    "text": "The consensus definition\nabout what you can perceive varies between 10% and 12%. So when I did this graph, it\nwas four or five years ago.",
    "start": "752760",
    "end": "760680"
  },
  {
    "text": "I drew the 12% line. There were 240 people in\nthe trial, 97 of which",
    "start": "760680",
    "end": "765779"
  },
  {
    "text": "improved their FEV1 by 12%\non the eighth day of therapy. They were then studied\non day 36, 64, and 92.",
    "start": "765780",
    "end": "773430"
  },
  {
    "text": "And this graph-- when I graphed\nthe data on my computer, it had all these lines\nlying on top of each other.",
    "start": "773430",
    "end": "778860"
  },
  {
    "text": "And they didn't get any thicker. So I can strain the data\nthrough this point here. So this isn't a data point.",
    "start": "778860",
    "end": "785070"
  },
  {
    "text": "But this is simply\nto allow you to see how many people are in this\ngroup that are in that group. It's a graphical\nrepresentation thing.",
    "start": "785070",
    "end": "791742"
  },
  {
    "text": "I mean, if I had clinical\ndata that looked like that, I wouldn't believe it.",
    "start": "791742",
    "end": "797440"
  },
  {
    "text": "So anyhow. What you can see is that of this\ngroup of people who improved, some actually got\nworse and stayed worse.",
    "start": "797440",
    "end": "804839"
  },
  {
    "text": "A lot of them got better\nand stayed better. And there were some that\nkind of moved around. If you follow the\ndots carefully,",
    "start": "804840",
    "end": "811540"
  },
  {
    "text": "you'll find that three\nfourths of the people are above this 12% line\non two of the three",
    "start": "811540",
    "end": "817830"
  },
  {
    "text": "subsequent occasions. So that's active\ntreatment with zileuton, which is the active drug.",
    "start": "817830",
    "end": "823350"
  },
  {
    "text": "Here are the same entry\ncriteria, same trial treated with placebo.",
    "start": "823350",
    "end": "828540"
  },
  {
    "text": "And you can see\nthat, as I told you, there are placebo responders. These people got better\nand stayed better.",
    "start": "828540",
    "end": "834180"
  },
  {
    "text": "In this trial,\nhowever, of the people who were above on day\neight, only about 40%",
    "start": "834180",
    "end": "840480"
  },
  {
    "text": "are persistently above the line. And, in fact, you can see there\nare a bunch of people here who flunked out.",
    "start": "840480",
    "end": "845740"
  },
  {
    "text": "And then they kind\nof went up and down.  Now if you look at the\npeople who don't get better.",
    "start": "845740",
    "end": "853360"
  },
  {
    "text": "These are nonresponders\nto treatment, which I defined as 5% or less. So I left myself a zone\nof middle response.",
    "start": "853360",
    "end": "860933"
  },
  {
    "text": "So there are a bunch of\npeople who don't get better. And, in general, if\nyou don't get better, you stay not better. Although there were a few people\nwho were kind of late bloomers.",
    "start": "860933",
    "end": "869939"
  },
  {
    "text": "It's a relatively\nsmall proportion. And when you look at placebo,\nit looks about the same.",
    "start": "869940",
    "end": "876700"
  },
  {
    "text": "So you can see why the\nnonresponse phenotypes a little better than the\nresponse phenotype in terms",
    "start": "876700",
    "end": "883350"
  },
  {
    "text": "of the noise. Because the people who don't\nget better and the placebo people who don't get better\nlook pretty much alike.",
    "start": "883350",
    "end": "890310"
  },
  {
    "text": "Well, the active treatment\nguys are contaminated by these people who you would say\nwere better when, in fact,",
    "start": "890310",
    "end": "897928"
  },
  {
    "text": "they weren't. So there you go. That should answer\nthe question there. So I can close this one.",
    "start": "897928",
    "end": "903990"
  },
  {
    "start": "903990",
    "end": "913230"
  },
  {
    "text": "I guess I closed the one\nI was still working on. Here you are. ",
    "start": "913230",
    "end": "920670"
  },
  {
    "text": "And so we're talking\nabout repeatability. ",
    "start": "920670",
    "end": "926842"
  },
  {
    "text": "Have you heard\nabout Sewall Wright and how he is a\npopulation geneticist? He did most of his work at\nthe University of Chicago.",
    "start": "926843",
    "end": "933805"
  },
  {
    "text": "And he died about\n15, 20 years ago. He wrote a four volume series\non human population genetics",
    "start": "933805",
    "end": "940800"
  },
  {
    "text": "before we had any\nmarkers or anything. And he kind of\nforecast and did a lot of the primary\nmathematics, which",
    "start": "940800",
    "end": "946590"
  },
  {
    "text": "are the basis of\npopulation epidemiology. And he actually\nderived an equation",
    "start": "946590",
    "end": "954450"
  },
  {
    "text": "for what he calls repeatability. Now what I would\nreally like to know is the heritability of the\nasthma treatment response.",
    "start": "954450",
    "end": "961740"
  },
  {
    "text": "But to do that,\nI'd have to study multigenerational families. And there are three\nproblems with that.",
    "start": "961740",
    "end": "967000"
  },
  {
    "text": "One is that asthma\ntreatment is changing. Second is that we know that an\nasthmatic at age 10, at age 25,",
    "start": "967000",
    "end": "975269"
  },
  {
    "text": "and at age 55 responds\ndifferently to treatment. Their disease tends to get\ningrained and unresponsive",
    "start": "975270",
    "end": "982740"
  },
  {
    "text": "to treatment. And so you'd have\nto be able to study, let's say, all the asthmatics\nwithin a family at age 20.",
    "start": "982740",
    "end": "989490"
  },
  {
    "text": "But the asthma treatment that\nyou gave the patient's father",
    "start": "989490",
    "end": "994620"
  },
  {
    "text": "is no longer available. There's something better. And so you aren't going to be\nable to get that treatment.",
    "start": "994620",
    "end": "999825"
  },
  {
    "text": "And, of course, the\npatient's father is now 50. And you can't treat him\nbecause the asthma treatment",
    "start": "999825",
    "end": "1007370"
  },
  {
    "text": "response varies. So it's going to be almost\nimpossible, I think, to get the data you need to\ndetermine the heritability",
    "start": "1007370",
    "end": "1013940"
  },
  {
    "text": "of asthma treatment. So we look at the repeatability. And the calculated\nrepeatability for beclomethasone",
    "start": "1013940",
    "end": "1021370"
  },
  {
    "text": "and montelukast from\nclinical trials. And we've done on the\norder of 80%, which",
    "start": "1021370",
    "end": "1026920"
  },
  {
    "text": "is good but not awesome. But repeatable enough\nwe think that there's",
    "start": "1026920",
    "end": "1033819"
  },
  {
    "text": "a pharmacogenetic signal. Yeah. AUDIENCE: I have just\na more basic question about what [INAUDIBLE]\nheritability [INAUDIBLE]..",
    "start": "1033819",
    "end": "1040609"
  },
  {
    "text": " JEFFREY MARK\nDRAZEN: So now we're",
    "start": "1040609",
    "end": "1045780"
  },
  {
    "text": "not talking about\nthe heritability of the asthmatic\ntreatment response. We're talking about the\nheritability of asthma.",
    "start": "1045780",
    "end": "1052860"
  },
  {
    "text": "And the asthmatic\nphenotype is got about-- in twin studies varies but\nis on the order of 65% or so,",
    "start": "1052860",
    "end": "1060360"
  },
  {
    "text": "comparing monozygotic\nand dizygotic twins. AUDIENCE: Is there any reason\nto connect those two [INAUDIBLE]",
    "start": "1060360",
    "end": "1066839"
  },
  {
    "text": "treatment? JEFFREY MARK DRAZEN: Well,\none of the real problems with asthma is that\nit's difficult--",
    "start": "1066839",
    "end": "1073520"
  },
  {
    "text": "it's like an\nimpressionistic picture. If I'm looking at\nit from 30 feet, it's easy to see\nwhat it's about.",
    "start": "1073520",
    "end": "1080010"
  },
  {
    "text": "As I get really close\nup, I lose the picture. And it's very difficult\nto define because there's",
    "start": "1080010",
    "end": "1086280"
  },
  {
    "text": "no biochemical test I can use. Quite often people look at\nthe theorem immunoglobulin E",
    "start": "1086280",
    "end": "1094150"
  },
  {
    "text": "levels. Because it's related to\nallergy but not asthma. But it's a very\nquantitative phenotype.",
    "start": "1094150",
    "end": "1100570"
  },
  {
    "text": "And so the definition of\nasthma is airway obstruction, which varies spontaneously\nas a result of treatment.",
    "start": "1100570",
    "end": "1106810"
  },
  {
    "text": "The problem is-- you\ntake two people that have the same genetic\nbackground, but one of them",
    "start": "1106810",
    "end": "1112409"
  },
  {
    "text": "is exposed to a lot more\nallergen than another. Even if you have monozygotic\ntwins and one of them",
    "start": "1112410",
    "end": "1119190"
  },
  {
    "text": "plays basketball, and\nchanges his clothes, and wears gym clothes that\nhave been sitting around in a ratty locker, and gets\nthat exposure every day",
    "start": "1119190",
    "end": "1128190"
  },
  {
    "text": "while the other one's\na swimmer and doesn't have the same kind of exposure,\none of them will develop asthma",
    "start": "1128190",
    "end": "1134700"
  },
  {
    "text": "and one may not. And so you'll say it's not\ninheritable when, in fact, it requires both a\ngenetic background",
    "start": "1134700",
    "end": "1140400"
  },
  {
    "text": "and an environmental exposure\nto manifest the phenotype. The classic examples\nare there a lot",
    "start": "1140400",
    "end": "1146760"
  },
  {
    "text": "of people from Hong Kong who\nhave latent ragweed allergy.",
    "start": "1146760",
    "end": "1152790"
  },
  {
    "text": "And they're OK in Hong Kong. There's no ragweed or very\nlittle in Hong Kong-- move",
    "start": "1152790",
    "end": "1158100"
  },
  {
    "text": "to the States where\nthere's a lot of ragweed. And they get really\nasthmatic in the fall. Well, they didn't have a problem\nback home because there wasn't",
    "start": "1158100",
    "end": "1164850"
  },
  {
    "text": "the allergen. Come here\nand they have allergen. And they get exposed.",
    "start": "1164850",
    "end": "1170090"
  },
  {
    "text": "So it's a combination of\nenvironment and genetics that appears to\nbring the disease on.",
    "start": "1170090",
    "end": "1176203"
  },
  {
    "text": "The research I'm going\nto tell you about represents the work of\na whole pile of people. This is most for the\npile, shown here.",
    "start": "1176203",
    "end": "1183622"
  },
  {
    "text": "There are people at the Channing\nlab, which is [? free-- ?] have heard from any of\nthese folks, [INAUDIBLE],,",
    "start": "1183622",
    "end": "1188669"
  },
  {
    "text": "I don't know. [? Zach ?] works\nwith some of them. The Pharmacogenomics\nResearch Network,",
    "start": "1188670",
    "end": "1193827"
  },
  {
    "text": "the Asthma Clinical\nResearch Network-- these are both NIH sponsored consortia\nthat I've been part of.",
    "start": "1193827",
    "end": "1202312"
  },
  {
    "text": "And the Whitehead Institute-- I'm sure you've all heard\nof those folks over at MIT. So I'm going to talk about\nthese three asthma treatments.",
    "start": "1202312",
    "end": "1210730"
  },
  {
    "text": "These are three of the\nmajor asthma treatments and what we know about\ntheir pharmacogenomics.",
    "start": "1210730",
    "end": "1217440"
  },
  {
    "text": "And we'll see how things go. So with this first one, we\nused a candidate gene strategy.",
    "start": "1217440",
    "end": "1223410"
  },
  {
    "text": "You're familiar with\ncandidate gene strategies? So this is work I started\nabout a decade ago.",
    "start": "1223410",
    "end": "1229470"
  },
  {
    "text": "I had a post-doc from Canada who\nwas interested in the problem. And I said, what we\nwant to do is to look",
    "start": "1229470",
    "end": "1237299"
  },
  {
    "text": "at the 5-lipoxygenase pathway. That's the leukotriene pathway.",
    "start": "1237300",
    "end": "1242760"
  },
  {
    "text": "Because we knew the\nbiochemistry of drugs. And I showed you the data,\nthe red and green lines",
    "start": "1242760",
    "end": "1249930"
  },
  {
    "text": "were from this\ndrugs zileuton that inhibits the action of\nthe enzyme 5-lipoxygenase. In fact, I've been involved in\nthe development of these four",
    "start": "1249930",
    "end": "1257340"
  },
  {
    "text": "drugs worldwide. And so we knew the\nstructure of this enzyme. We knew its genomic sequence.",
    "start": "1257340",
    "end": "1264150"
  },
  {
    "text": "And our question was, when you\nhave patients with asthma who show up in your\noffice, they all have",
    "start": "1264150",
    "end": "1271350"
  },
  {
    "text": "phenotypically similar asthma. But we think that some\nof them may have asthma because they have an excess\nof 5-lipoxygenase products",
    "start": "1271350",
    "end": "1278520"
  },
  {
    "text": "and stimulation\nat this receptor. But a clinically\nindistinguishable phenotype can be someone that has asthma\ndue to an excess of substance",
    "start": "1278520",
    "end": "1287100"
  },
  {
    "text": "P, a neuropeptide having\nnothing to do with this. Or you can have somebody that\nhas excessive of histamine,",
    "start": "1287100",
    "end": "1294060"
  },
  {
    "text": "or someone that has an excess\nof neurokinin A, or endothelin. So there are\nprobably half a dozen",
    "start": "1294060",
    "end": "1300630"
  },
  {
    "text": "endogenous\nbronchoconstrictors, which have totally different\nbiochemical pathways that",
    "start": "1300630",
    "end": "1306270"
  },
  {
    "text": "can lead to the same\nclinical phenotype. And so you recognize\nthat as asthma.",
    "start": "1306270",
    "end": "1312930"
  },
  {
    "text": "And they probably\nrepresent people that have a\ndifferent genetically programmed mast cells\nin neural responses.",
    "start": "1312930",
    "end": "1321460"
  },
  {
    "text": "So are argument went\nthat if you could look at the variability of the\ntreatment response here related",
    "start": "1321460",
    "end": "1329400"
  },
  {
    "text": "to the enzymes in\nthis pathway, you'd be able to begin to pick\nout people whose asthma was",
    "start": "1329400",
    "end": "1334620"
  },
  {
    "text": "associated with leukotrienes\nand specifically whether there would be variability here.",
    "start": "1334620",
    "end": "1339820"
  },
  {
    "text": "So what we started\nwith is we had the human 5-lipoxygenase gene.",
    "start": "1339820",
    "end": "1346440"
  },
  {
    "text": "We knew it's intron\nand exonic structure. When I started the work, this\nwas hot, new information.",
    "start": "1346440",
    "end": "1353263"
  },
  {
    "text": "And this guy from Canada worked\non the problem for a month and quit. He said it was too hard. And I was really blessed.",
    "start": "1353263",
    "end": "1359100"
  },
  {
    "text": "I had a post-doctoral\nfellow from Korea-- actually he was a\nvisiting scientist.",
    "start": "1359100",
    "end": "1364150"
  },
  {
    "text": "And he's probably the\nmost patient person in the entire world, I think. And he plowed his way through\nthis gene, exon by exon,",
    "start": "1364150",
    "end": "1372740"
  },
  {
    "text": "doing old-fashioned\nsequencing, SSCP.",
    "start": "1372740",
    "end": "1378440"
  },
  {
    "text": "And this took him\nalmost three years. This kind of work now\ntakes three weeks or maybe three days, depending on what\nkind of genotyping outfit",
    "start": "1378440",
    "end": "1385430"
  },
  {
    "text": "you have. And what he found, which\nwas quite discouraging, was that there were no common--",
    "start": "1385430",
    "end": "1390650"
  },
  {
    "text": "that is alleles greater\nthan the frequency 0.15-- DNA sequence variants\nleading to a modified protein",
    "start": "1390650",
    "end": "1396320"
  },
  {
    "text": "sequence in the entire\n5-lipoxygenase gene. You got a question or\nare you just stretching?",
    "start": "1396320",
    "end": "1402110"
  },
  {
    "text": "Wouldn't want to have a\npulmonary embolism over there. So there were,\nhowever, variations",
    "start": "1402110",
    "end": "1408590"
  },
  {
    "text": "in the transcription\nfactor binding region, which is just upstream. It's the 5-LO gene promoter.",
    "start": "1408590",
    "end": "1414300"
  },
  {
    "text": "Now what was known about the\ngene promoter at that time, which has actually hung\nin there to be true,",
    "start": "1414300",
    "end": "1419630"
  },
  {
    "text": "is it just the head of the\ntranslation start site, there are a series of SP1\nand EGR1 binding motifs.",
    "start": "1419630",
    "end": "1427520"
  },
  {
    "text": "In fact, there are\nfive of them in tandem.",
    "start": "1427520",
    "end": "1432590"
  },
  {
    "text": "Then if you search\nthe GenBank, this is the only gene\nwhere that occurs.",
    "start": "1432590",
    "end": "1438420"
  },
  {
    "text": "So the sequence GGGCGG\nis repeated over and over and over again. And that's just right\nin the core promoter.",
    "start": "1438420",
    "end": "1446137"
  },
  {
    "text": "And that's where the\nsequence variants were found. In fact, the sequence\nin the GenBank",
    "start": "1446137",
    "end": "1452090"
  },
  {
    "text": "has five of these in a row. And we've identified individuals\nwith 3, 4, and 6, and 7, less",
    "start": "1452090",
    "end": "1461330"
  },
  {
    "text": "commonly, we've, in fact,\nidentified people with 2. And so this is a variable\nnucleotide tandem repeat.",
    "start": "1461330",
    "end": "1467030"
  },
  {
    "text": "People could use\nit for genotyping. But we showed that it read true. So it's not one that\nit tends to expand.",
    "start": "1467030",
    "end": "1473990"
  },
  {
    "text": "It's not like it is in\nHuntington's disease. If your mother and father\nhave different alleles",
    "start": "1473990",
    "end": "1481922"
  },
  {
    "text": "and are homozygous\nfor them, you're going to be a heterozygous. So we did enough\nfamily studies to know",
    "start": "1481922",
    "end": "1487730"
  },
  {
    "text": "that this was a stable VNTR. And then what we did was\nwe took human cells--",
    "start": "1487730",
    "end": "1496640"
  },
  {
    "text": "these are HeLa cells-- and transected them with\nthe wild type promoter",
    "start": "1496640",
    "end": "1502130"
  },
  {
    "text": "and promoters which\nhas five repeats, and with 3, 4, and 6 repeats.",
    "start": "1502130",
    "end": "1509450"
  },
  {
    "text": "And studied them in\na CAT assay, this is a chloramphenicol\nacetyltransferase assay. So the higher the bar, the\ngreater the promoter activity.",
    "start": "1509450",
    "end": "1517473"
  },
  {
    "text": "And you can see that\nall the mutants are less effective at driving\ngene transcription",
    "start": "1517473",
    "end": "1522500"
  },
  {
    "text": "than the wild type. Now this is one of these\nmoments that you never forget",
    "start": "1522500",
    "end": "1527507"
  },
  {
    "text": "in clinical investigation. I was going over these\ndata with Tucker Collins, who's a professor of\npathology at Brigham now.",
    "start": "1527507",
    "end": "1534338"
  },
  {
    "text": "And he looked at\nthese data and says, you know, Drazen,\nyou're absolutely right. But you've got to\nfind something else to do because these\nvariations are too small.",
    "start": "1534338",
    "end": "1543710"
  },
  {
    "text": "No one wants to\nstudy a 35% or 40% decrease in CAT transferase\nactivities, too small.",
    "start": "1543710",
    "end": "1552110"
  },
  {
    "text": "But what I knew\nfrom clinical trials was that if I inhibited\n5-lipoxygenase 35% or 40%,",
    "start": "1552110",
    "end": "1559100"
  },
  {
    "text": "that I got a very\nsubstantial clinical benefit. So the argument that\nwe had in our head",
    "start": "1559100",
    "end": "1565700"
  },
  {
    "text": "was that if patients\nwith variations in the 5-lipoxygenase,\nthe ALOX5 promoter,",
    "start": "1565700",
    "end": "1575210"
  },
  {
    "text": "had downregulated\nALOX5 production, but they wouldn't respond to\nantileukotriene treatment.",
    "start": "1575210",
    "end": "1583800"
  },
  {
    "text": "The idea is that patients\nwith this funny form of the core promoter would\nhave some other cause",
    "start": "1583800",
    "end": "1592549"
  },
  {
    "text": "for their asthma. Their asthma may be due to the\nhistamines, or to substance P,",
    "start": "1592550",
    "end": "1599330"
  },
  {
    "text": "or some other variant,\nsome other mediator, but that leukotrienes\nwouldn't be important.",
    "start": "1599330",
    "end": "1606230"
  },
  {
    "text": "Because these are all\ndownregulatory mutations. So I was lucky, at the time,\nbecause Abbott Pharmaceuticals",
    "start": "1606230",
    "end": "1613010"
  },
  {
    "text": "had developed the 5-lipoxygenase\ninhibitors zileuton. And it had two big problems\nthey were trying to overcome.",
    "start": "1613010",
    "end": "1619940"
  },
  {
    "text": "One is that it has to be given\nto patients four times a day.",
    "start": "1619940",
    "end": "1625250"
  },
  {
    "text": "And that's a pain. If you give patients the pill to\ntake once a day, they'll do it.",
    "start": "1625250",
    "end": "1632150"
  },
  {
    "text": "Twice a day is harder. Three times a day\nrequires a saint. And four times a\nday requires God.",
    "start": "1632150",
    "end": "1637850"
  },
  {
    "text": "It's almost impossible to do it. Now I did actually have patients\nthat had pretty bad asthma",
    "start": "1637850",
    "end": "1644990"
  },
  {
    "text": "that took it four times a day. So Abbott developed the compound\nyou could take twice a day. The second problem for\nthem was that about 3%",
    "start": "1644990",
    "end": "1654080"
  },
  {
    "text": "of people that took this\ndrug developed abnormalities in liver function tests.",
    "start": "1654080",
    "end": "1659539"
  },
  {
    "text": "And although nobody had a liver\nthat checked out on this drug, it required monitoring\nof the whole population",
    "start": "1659540",
    "end": "1667115"
  },
  {
    "text": "to find the 3% or\n4% of people who had an adverse hepatic response. It's a very common problem\nin drug development.",
    "start": "1667115",
    "end": "1674130"
  },
  {
    "text": "And so they came\nup with a daughter of zileuton, which wasn't\nsupposed to have this problem. And it was called ABT 761.",
    "start": "1674130",
    "end": "1680700"
  },
  {
    "text": "It acted at the same location. And that was the plan. So it was the clinical\ntrial that we designed.",
    "start": "1680700",
    "end": "1686669"
  },
  {
    "text": "I actually helped design it. This was not a high-tech\nclinical trial.",
    "start": "1686670",
    "end": "1692520"
  },
  {
    "text": "We enrolled patients\non no treatment. And we assigned them to--\nthese were asthma patients--",
    "start": "1692520",
    "end": "1697890"
  },
  {
    "text": "to ABT-761 or a placebo. And since they were patients\nthat we found on no treatment,",
    "start": "1697890",
    "end": "1703620"
  },
  {
    "text": "continuing them on no treatment\nseemed like it was no problem. Now this was seven\nor eight years ago.",
    "start": "1703620",
    "end": "1708960"
  },
  {
    "text": "Asthma treatments progressed. It would be harder\nto do this trial now. Because there are a lot of\npeople who didn't get treatment",
    "start": "1708960",
    "end": "1715413"
  },
  {
    "text": "[? who would. ?] So what happened was\nwe genotyped everybody at the 5-lipoxygenase locus. And as we expected--",
    "start": "1715413",
    "end": "1721990"
  },
  {
    "text": "oh, I forgot to tell\nyou one more thing which was that when the trial was\nset up, Abbott, to save money,",
    "start": "1721990",
    "end": "1728730"
  },
  {
    "text": "said, look, when a third\nof the patients complete-- you don't enroll everybody\nin the first day. Usually, it takes a couple\nof years to enroll--",
    "start": "1728730",
    "end": "1735473"
  },
  {
    "text": "but when the third\nof the patients complete their 12\nweeks, we're going to compare the incidence\nof liver function tests",
    "start": "1735473",
    "end": "1741150"
  },
  {
    "text": "in the placebo\nand ABT-761 group. And if this drug isn't improving\nthe rate of adverse effects,",
    "start": "1741150",
    "end": "1747400"
  },
  {
    "text": "we're going to stop the trial. Because it's not worth\nanother $40 million to find out something\nwe don't want to know,",
    "start": "1747400",
    "end": "1753900"
  },
  {
    "text": "which was that this\ndrug wasn't in advance. Because they were hoping\nit would be in advance. And I thought that was a very\nreasonable approach to life.",
    "start": "1753900",
    "end": "1760409"
  },
  {
    "text": "So we genotyped everybody. And as you might expect,\nthe wild type allele occurred most commonly, made\nup about 81% of the alleles.",
    "start": "1760410",
    "end": "1767580"
  },
  {
    "text": "The deletion alleles three\nand four made up 19%. The addition allele\nsix was so rare--",
    "start": "1767580",
    "end": "1775830"
  },
  {
    "text": "with one patient with\nit-- that it really didn't add up to much.",
    "start": "1775830",
    "end": "1780990"
  },
  {
    "text": "So when we stratified\nthe results of FEV1 by genotype, the patients\nthat received active treatment",
    "start": "1780990",
    "end": "1790169"
  },
  {
    "text": "and where the wild\ntype genotype, 55, improved their FEV1 about 17%.",
    "start": "1790170",
    "end": "1797070"
  },
  {
    "text": "Patients on placebo with the\n55 genotype improved FEV1 5%.",
    "start": "1797070",
    "end": "1803250"
  },
  {
    "text": "Now it turned out\nthat there were 14 patients that had active\ntreatment that had no 5 allele.",
    "start": "1803250",
    "end": "1809679"
  },
  {
    "text": "So we called them active XX. And they actually had\ntheir FEV1 get worse.",
    "start": "1809680",
    "end": "1814770"
  },
  {
    "text": "And since we didn't stratify\nthe enrollment by genotype, it turned out there was\nonly one patient that",
    "start": "1814770",
    "end": "1820290"
  },
  {
    "text": "had XX genotype on placebo. And that person got better. But that's one patient.",
    "start": "1820290",
    "end": "1825923"
  },
  {
    "text": "It's hard to make any\nsense out of that. So the p-value for\nthis change in FEV1",
    "start": "1825923",
    "end": "1831870"
  },
  {
    "text": "was 10 to the minus fifth. This is unlikely to\nhave happened by chance.",
    "start": "1831870",
    "end": "1837159"
  },
  {
    "text": "But when we went into the trial\nbased on a preliminary analysis of the data set that we never\npublished because we were",
    "start": "1837160",
    "end": "1844800"
  },
  {
    "text": "concerned about bias in\nascertaining the patients, we had thought that\nheterozygosity at this locus",
    "start": "1844800",
    "end": "1851850"
  },
  {
    "text": "would contribute\nto the phenotype. And it turned out that\nthat's not the case. You had to be homozygous.",
    "start": "1851850",
    "end": "1857430"
  },
  {
    "text": "So that the allele frequency\nhere is 0.19 squared. So it's very small. It's about 3% or 4%\nof the population.",
    "start": "1857430",
    "end": "1864460"
  },
  {
    "text": "So from a pharmacogenetic\nperspective, it's interesting, but it's not\neconomically interesting.",
    "start": "1864460",
    "end": "1871179"
  },
  {
    "text": "On the other hand, if it had\nbeen 20% of the population, it would have been interesting. Because if you assume that you\ncould do a genotype for $50",
    "start": "1871180",
    "end": "1877289"
  },
  {
    "text": "bucks. It's easier to treat\nthe patient and see if they get better than genotype\n100 people to find people",
    "start": "1877290",
    "end": "1883470"
  },
  {
    "text": "three people who aren't\ngoing to get better. Since there are\nalso probably other reasons that you don't get\nbetter with this treatment",
    "start": "1883470",
    "end": "1890058"
  },
  {
    "text": "other than this genotype. So it turned out to be\npharmacoeconomically not very interesting.",
    "start": "1890058",
    "end": "1895280"
  },
  {
    "text": "Now it turned out that some\nwork we did at the same time was that we got eosinophils.",
    "start": "1895280",
    "end": "1902460"
  },
  {
    "text": "And we look for the\nexpression of mRNA by PCR of the ALOX5 gene. This is our control\nwith [INAUDIBLE]..",
    "start": "1902460",
    "end": "1909240"
  },
  {
    "text": "Then we had five patients\nhere with a 55 genotype. In most of them,\nbut not all of them,",
    "start": "1909240",
    "end": "1916919"
  },
  {
    "text": "have relatively high\nlevels of the five well picked up ALOX5\npicked up by PCR.",
    "start": "1916920",
    "end": "1922890"
  },
  {
    "text": "But none of the three patients\nthat we did that had no 5 allele had this availability.",
    "start": "1922890",
    "end": "1930450"
  },
  {
    "text": "And then we looked at\nthe amount of LPC-4, that is the leukotrienes\nproduced by these NFLs.",
    "start": "1930450",
    "end": "1938370"
  },
  {
    "text": "The deletional variance--\nthere were four patients for that compared to five here.",
    "start": "1938370",
    "end": "1944122"
  },
  {
    "text": "There was a\nsignificant difference in terms of lesser amounts\nof leukotrienes produced.",
    "start": "1944123",
    "end": "1949350"
  },
  {
    "text": "So that suggested that there\nwas variation in this pathway.",
    "start": "1949350",
    "end": "1955260"
  },
  {
    "text": "We've since looked at the\ncytosolic phospholipase A2, the LPC-4 synthase,\nthe epoxide hydrolase, all the other genes\nin this pathway.",
    "start": "1955260",
    "end": "1962280"
  },
  {
    "text": "And we haven't found\nany other variance related to treatment response. ",
    "start": "1962280",
    "end": "1968100"
  },
  {
    "text": "But we did find--\nand this is actually interesting confirmatory data. And this is not our work\nbut the work of others.",
    "start": "1968100",
    "end": "1974880"
  },
  {
    "text": "What they reasoned was\nthat if the variance that changed the amount\nof look leukotriene",
    "start": "1974880",
    "end": "1982080"
  },
  {
    "text": "produced, that you should get\nthe same pharmacogenetic effect if patients are treated with\none of these drugs, which",
    "start": "1982080",
    "end": "1988200"
  },
  {
    "text": "rather than inhibiting the\nenzyme are receptor inhibitors. ",
    "start": "1988200",
    "end": "1994850"
  },
  {
    "text": "In fact, I'll tell you\nthat in the trials done",
    "start": "1994850",
    "end": "2002570"
  },
  {
    "text": "with the receptor\ninhibitors by others, patients with the mutant\nform of the genotype",
    "start": "2002570",
    "end": "2008000"
  },
  {
    "text": "don't respond to the\nreceptor inhibitor, so confirming our data. It's always heart-warming.",
    "start": "2008000",
    "end": "2013940"
  },
  {
    "text": "So it suggests that\nvariations in this pathway can contribute to a small\nfraction of the variance.",
    "start": "2013940",
    "end": "2019890"
  },
  {
    "text": "So I think it's interesting\npharmacogenetics. But it never made it\npharmacoeconomically",
    "start": "2019890",
    "end": "2025250"
  },
  {
    "text": "because it's a too small\nproportion of the population. We really have to, I\nthink, affect 15%--",
    "start": "2025250",
    "end": "2032480"
  },
  {
    "text": "unless you're talking about\na serious toxic event. Now, for example, with the gene\nthiopurine methyltransferase,",
    "start": "2032480",
    "end": "2042470"
  },
  {
    "text": "which is a gene involved in the\nmetabolism of 6-mercaptopurine,",
    "start": "2042470",
    "end": "2048020"
  },
  {
    "text": "which is a drug used\nto treat leukemia. Among members of the\npopulation, especially people",
    "start": "2048020",
    "end": "2053810"
  },
  {
    "text": "of Scandinavian heritage,\nabout 2% or 3% of those people",
    "start": "2053810",
    "end": "2059570"
  },
  {
    "text": "harbor an allele\nwhere they don't metabolize 6-mercaptopurine\nat the rate they should.",
    "start": "2059570",
    "end": "2066449"
  },
  {
    "text": "And so if you give them the\nstandard dose, they get toxic. And you can actually\nkill them with the drug.",
    "start": "2066449",
    "end": "2073638"
  },
  {
    "text": "So when you're treating\nleukemia now with that drug,",
    "start": "2073639",
    "end": "2079010"
  },
  {
    "text": "it's standard to\ngenotype people to make sure they don't have one\nof these slow-metabolizing",
    "start": "2079010",
    "end": "2084530"
  },
  {
    "text": "alleles. And they're now you're\nlooking for a life threatening toxicity, which occurs\nat low frequency.",
    "start": "2084530",
    "end": "2091429"
  },
  {
    "text": "But because the\nconsequences of missing it are so dramatic and\nso irreversible,",
    "start": "2091429",
    "end": "2101000"
  },
  {
    "text": "it makes sense to screen\n1,000 people to find one. In fact, if you screen\nsomeone in Asia, you have to screen almost\n5,000 people to find one.",
    "start": "2101000",
    "end": "2109550"
  },
  {
    "text": "But yet, in treating\nleukemia in Asia, they're still doing\nit, just because it's something that can be prevented\nif you're going to a higher",
    "start": "2109550",
    "end": "2116720"
  },
  {
    "text": "class treatment center. Well, if you were screening\nat the Mayo Clinic where there's a lot\nof Scandinavian blood,",
    "start": "2116720",
    "end": "2123020"
  },
  {
    "text": "really make sense to do it. But for something like\nthis, where the failure",
    "start": "2123020",
    "end": "2128480"
  },
  {
    "text": "to respond to treatment\nis a nuisance as opposed to a\nlife-threatening event, it didn't make\npharmacoeconomic sense.",
    "start": "2128480",
    "end": "2136440"
  },
  {
    "text": "So my second example is\nabout inhaled steroids. And steroids are different\nfrom antileukotrienes",
    "start": "2136440",
    "end": "2144110"
  },
  {
    "text": "because we knew how\nantileukotrienes work in asthma. I mean, they were developed\nbased on understanding",
    "start": "2144110",
    "end": "2150270"
  },
  {
    "text": "of the biology of asthma.  But inhaled steroids we knew\nworked based on observation.",
    "start": "2150270",
    "end": "2158510"
  },
  {
    "text": "But steroids have thousands of\npotential mechanisms of action. We had no idea which\none was accurate.",
    "start": "2158510",
    "end": "2166470"
  },
  {
    "text": "So some of this study\nis useful because if I can find a gene that\ncontrols steroid response,",
    "start": "2166470",
    "end": "2174349"
  },
  {
    "text": "maybe that's telling\nme a gene that's important in the\nbiology of asthma. And then, I could\ndevelop a treatment",
    "start": "2174350",
    "end": "2180920"
  },
  {
    "text": "that inhibited just\nthat gene and wouldn't have a lot of the side\neffects of steroids.",
    "start": "2180920",
    "end": "2186500"
  },
  {
    "text": "Because one of the big\nproblems with treating asthma with steroids is that if you're\na kid, it makes you shorter.",
    "start": "2186500",
    "end": "2193640"
  },
  {
    "text": "If you're an adult, it\nmakes your bones brittle. It causes acne to break\nout, causes skin to thin.",
    "start": "2193640",
    "end": "2199640"
  },
  {
    "text": "It's got a lot of side effects\nthat aren't terribly good. And to get rid of\nthose side effects",
    "start": "2199640",
    "end": "2207349"
  },
  {
    "text": "would be good until\nyou can get at it. At the same time,\nwith inhaled steroids, just like with\nantileukotrienes, you",
    "start": "2207350",
    "end": "2213380"
  },
  {
    "text": "saw that there are about 40% of\npeople who are paying for drugs who aren't getting any benefit.",
    "start": "2213380",
    "end": "2219290"
  },
  {
    "text": "But the drug companies\nthink that's perfectly fine. I don't. Because they're getting\nthe toxic effects, we know.",
    "start": "2219290",
    "end": "2226310"
  },
  {
    "text": "But they're not getting\nthe therapeutic benefit. And it's costing them $50\nbucks a month, sometimes more.",
    "start": "2226310",
    "end": "2231800"
  },
  {
    "text": "The new inhaled\nsteroids are actually $60 to $75 bucks a month. So it's an expensive habit.",
    "start": "2231800",
    "end": "2236900"
  },
  {
    "text": "It's a lot like\nyour coffee habit. If you buy a couple of cups\nof coffee at the Starbucks",
    "start": "2236900",
    "end": "2243440"
  },
  {
    "text": "or even at the place\ndown here, you're spending two 2 and 1/2\nbucks a day on coffee. Works out $70 bucks a month.",
    "start": "2243440",
    "end": "2248960"
  },
  {
    "text": "That's what an\nasthma attack costs. So here we are showing\ntwo more populations.",
    "start": "2248960",
    "end": "2254660"
  },
  {
    "text": "I showed you the\npurple population with the beclomethasone\nThere are two",
    "start": "2254660",
    "end": "2261410"
  },
  {
    "text": "different inhaled steroids-- different from the ones I\nshowed you-- showing a variation",
    "start": "2261410",
    "end": "2266980"
  },
  {
    "text": "treatment response\nquite similar to the one that I showed you from\nthat asthma trial. Now, these two populations\nare ones that we studied.",
    "start": "2266980",
    "end": "2274550"
  },
  {
    "text": "This is actually a\ndrug company study done by Forest Labs of one\nof their inhaled steroids.",
    "start": "2274550",
    "end": "2281539"
  },
  {
    "text": "And this was one sponsored\nby the NIH called the Childhood Asthma\nManagement Program or CAMP.",
    "start": "2281540",
    "end": "2287740"
  },
  {
    "text": "And even though ones kids and\nones adults, totally different study designs, you see\nthis same variation",
    "start": "2287740",
    "end": "2295119"
  },
  {
    "text": "in the asthma treatment\nresponse to inhaled steroids in three populations,\nallowing one to believe it's highly\nlikely to be true.",
    "start": "2295120",
    "end": "2302869"
  },
  {
    "text": "So what we did here is we have\na different candidate gene strategy. And the 5-lipoxygenase-- we\nknew the genes in the pathway.",
    "start": "2302870",
    "end": "2310369"
  },
  {
    "text": "And we could identify them based\non how the treatment worked. Here, we were guessing\nhow the treatment worked.",
    "start": "2310370",
    "end": "2317680"
  },
  {
    "text": "So we got a bunch of\npeople around in a room who we thought knew about steroids. And we compiled the list of\npossible genes in the pathway.",
    "start": "2317680",
    "end": "2325540"
  },
  {
    "text": "We then looked for DNA sequence\nvariance in that pathway. We then look to see if there's\na statistical relationship",
    "start": "2325540",
    "end": "2331960"
  },
  {
    "text": "between clinical response and\nthe presence of the sequence variant. And then we determined\ntheir functional relevance.",
    "start": "2331960",
    "end": "2337539"
  },
  {
    "text": "And so I don't need\nto define SNPs, right? You all know about SNPs\nand haplotypes, right?",
    "start": "2337540",
    "end": "2343510"
  },
  {
    "text": "Talked all about that. So here's our strategy. ",
    "start": "2343510",
    "end": "2349160"
  },
  {
    "text": "We have 32 control and\n16 asthmatic cell lines,",
    "start": "2349160",
    "end": "2354190"
  },
  {
    "text": "which we had an infinite\namount of DNA from. And we identified variants from\nsequencing and from a database.",
    "start": "2354190",
    "end": "2363369"
  },
  {
    "text": "We then selected SNPs based\non the allele frequency. We designed genotyping assays\nand did primary genotyping",
    "start": "2363370",
    "end": "2371050"
  },
  {
    "text": "in the adult study-- that\nwas the drug company study-- of cases and controls.",
    "start": "2371050",
    "end": "2376135"
  },
  {
    "start": "2376135",
    "end": "2386860"
  },
  {
    "text": "What we were using\nis cases and controls was comparing people at\nthis end of the graph to people at that\nend of the graph.",
    "start": "2386860",
    "end": "2392890"
  },
  {
    "text": "So we call these controls and\nthese cases or vice versa. ",
    "start": "2392890",
    "end": "2400730"
  },
  {
    "text": "And then we would identify\nhaplotype tag SNPs that had greater than 5% prevalence.",
    "start": "2400730",
    "end": "2406809"
  },
  {
    "text": "And that gave us\nfirst [INAUDIBLE] [? statistical ?] associations\nin the adult population.",
    "start": "2406810",
    "end": "2412280"
  },
  {
    "text": "We then said if this is true, we\nshould be able to replicate it in the kids.",
    "start": "2412280",
    "end": "2417549"
  },
  {
    "text": "And then we said\nif it's true still, should be able to replicate\nit in a third population.",
    "start": "2417550",
    "end": "2423349"
  },
  {
    "text": "And then we did some\nfancy statistics on it. So here are the three\npopulations we studied.",
    "start": "2423350",
    "end": "2431619"
  },
  {
    "text": "This adult study is\na drug company study, eight weeks in duration,\npeople whose lung function as a percent\n[INAUDIBLE] is 70% to start.",
    "start": "2431620",
    "end": "2439695"
  },
  {
    "text": "They're adults. They're age 40. And they're interesting. Their steroid response\nis 7% on average.",
    "start": "2439695",
    "end": "2448270"
  },
  {
    "text": "In the CAMP trial, which is our\nfirst replicate, they're kids. So their average age is 9.",
    "start": "2448270",
    "end": "2455109"
  },
  {
    "text": "The trial duration\nwas four years not four weeks or four months.",
    "start": "2455110",
    "end": "2460330"
  },
  {
    "text": "And their average\nimprovement FEV1 is 7%. And then our second\nreplication trial--",
    "start": "2460330",
    "end": "2466250"
  },
  {
    "text": "was government\nsponsored, six weeks. Again, average\nimprovements about 7%.",
    "start": "2466250",
    "end": "2472130"
  },
  {
    "text": "So this is about what you\nget in these populations. This kind of population, you\nget about 7% improvement FEV1.",
    "start": "2472130",
    "end": "2477880"
  },
  {
    "text": "This is the list of genes\nthat we interrogated. And this was simply a\nlist of genes made up",
    "start": "2477880",
    "end": "2485109"
  },
  {
    "text": "by understanding the\npathway, thinking how it could impinge on asthma.",
    "start": "2485110",
    "end": "2490339"
  },
  {
    "text": "So it's entirely theoretical. And so here our primary outcome\nusing the single SNP analysis--",
    "start": "2490340",
    "end": "2499599"
  },
  {
    "text": "these are haplotype tag SNPs. So in the adult\nstudy, RS-242941,",
    "start": "2499600",
    "end": "2507190"
  },
  {
    "text": "so this is just the name of one\nof these haplotype tag SNPs-- using the eight-week\nFEV1 percent change",
    "start": "2507190",
    "end": "2513670"
  },
  {
    "text": "as a continuous variable,\ngave us a p-value of 0.025.",
    "start": "2513670",
    "end": "2521950"
  },
  {
    "text": "This is adjusted for\ncovariates but not for the number of [? looks. ?]\nWe then did it in a CAMP",
    "start": "2521950",
    "end": "2529119"
  },
  {
    "text": "population, now many\nfewer looks, again eight-week percent change,\ncontinuous variable,",
    "start": "2529120",
    "end": "2536349"
  },
  {
    "text": "p-value of 0.006. So you're on a roll. And we looked at that same\ngenotype in the ACRN population",
    "start": "2536350",
    "end": "2544720"
  },
  {
    "text": "and didn't find a relationship.",
    "start": "2544720",
    "end": "2549880"
  },
  {
    "text": "That would have\nbeen hitting gold. So we got silver\nor some other load.",
    "start": "2549880",
    "end": "2556660"
  },
  {
    "text": "I'm not quite sure what\nyou want to call it. But we found that these are\nthree other haplotype tag SNPs.",
    "start": "2556660",
    "end": "2565150"
  },
  {
    "text": "That this one, RS-1876828, which\nis in the same gene, CRHR1,",
    "start": "2565150",
    "end": "2574329"
  },
  {
    "text": "cortical troponin releasing\nhormone receptor 1,",
    "start": "2574330",
    "end": "2579850"
  },
  {
    "text": "was positive in\nboth populations. So we got either\nsecond or third prize, depending on your perspective.",
    "start": "2579850",
    "end": "2586150"
  },
  {
    "text": "The ideal would have been to\nhave the same haplotype tags SNP positive in all\nthree populations.",
    "start": "2586150",
    "end": "2592420"
  },
  {
    "text": "What we found was\ndifferent haplotype tags SNPs in the same gene,\nsuggesting that it's",
    "start": "2592420",
    "end": "2600910"
  },
  {
    "text": "the gene that's the problem\nbut not localizing the site,",
    "start": "2600910",
    "end": "2606460"
  },
  {
    "text": "not actually getting to what\nwe think is the active problem. So the half-full way of\nlooking at these data",
    "start": "2606460",
    "end": "2616150"
  },
  {
    "text": "are that, gee, although I\ndon't know the mechanism, if I genotype people\nat these loci,",
    "start": "2616150",
    "end": "2624070"
  },
  {
    "text": "can I predict their\nresponse in lung function? So this is the RS-242941.",
    "start": "2624070",
    "end": "2634720"
  },
  {
    "text": "That was the top one in the\nkids CAMP and the adults. And what we've not done is\ntaken this haplotype tag SNP",
    "start": "2634720",
    "end": "2643240"
  },
  {
    "text": "and looked at people who\nwere homozygous for it, and heterozygous, and didn't\nhave any copies of it.",
    "start": "2643240",
    "end": "2650680"
  },
  {
    "text": "And you can see that if\nyou own this phenotype, that your improvement in FEV1 is\nalmost twice as great as if you",
    "start": "2650680",
    "end": "2657850"
  },
  {
    "text": "own this genotype on average. When you look at a\ndifferent haplotype.",
    "start": "2657850",
    "end": "2666430"
  },
  {
    "text": "This is GAT haplotype pair. And this is now in the\nadult and the CAMP study.",
    "start": "2666430",
    "end": "2672720"
  },
  {
    "text": "Even it's a little\nmore informative here. I can show you the difference\nin the size of these bars. Here, this is\nabout a 10% to 15%.",
    "start": "2672720",
    "end": "2681520"
  },
  {
    "text": "If you look here, this\nis now 15% to 20%. This is a little bigger response\nin people with this haplotype",
    "start": "2681520",
    "end": "2688000"
  },
  {
    "text": "compared to people without it. So we think that it has\nsome predictive value.",
    "start": "2688000",
    "end": "2694030"
  },
  {
    "text": "It did not turn out to be\nstatistically significant, as I said again, in\nthe ACRN population,",
    "start": "2694030",
    "end": "2699590"
  },
  {
    "text": "smaller number of people. It was in the right sign but\nnot statistically significant.",
    "start": "2699590",
    "end": "2705299"
  },
  {
    "text": "This is a different\ngenotype in that same gene but a different\nSNP, the RS-1876828,",
    "start": "2705300",
    "end": "2712640"
  },
  {
    "text": "showing again that if you're\nhomozygous AA versus GG, a big difference in response.",
    "start": "2712640",
    "end": "2719970"
  },
  {
    "text": "But when we went back\nand did this population with that genotype,\nit didn't work out.",
    "start": "2719970",
    "end": "2727650"
  },
  {
    "text": "The second thing we learned\nis that CRHR1 is probably involved in the of the\nasthma treatment response,",
    "start": "2727650",
    "end": "2733490"
  },
  {
    "text": "suggesting that if\nyou could target CRHR1 antagonist to the\nlung, where CRHR1 receptor.",
    "start": "2733490",
    "end": "2739760"
  },
  {
    "text": "It's a seven-transmembrane\nspanning G protein coupled receptor. It's got a bunch of\nligands in addition",
    "start": "2739760",
    "end": "2745100"
  },
  {
    "text": "to corticotropin releasing\nhormone that can activate it.",
    "start": "2745100",
    "end": "2750450"
  },
  {
    "text": "So some of the questions are,\ncan you find it in the lung? So this is one of\nthese body blots",
    "start": "2750450",
    "end": "2755720"
  },
  {
    "text": "that you buy from one of\nthose companies out west.",
    "start": "2755720",
    "end": "2761300"
  },
  {
    "text": "[? Say, ?] oh, [? it's ?]\nRNA, if you do, what we did here is\n12 cycles of PCR.",
    "start": "2761300",
    "end": "2768130"
  },
  {
    "text": "And you pick it up in\nthe positive control and in the brain. This is a hypothalamic hormone. So the fact that you find the\nhypothalamic hormone receptor",
    "start": "2768130",
    "end": "2775048"
  },
  {
    "text": "in the brain is no surprise. If you do twice as\nmuch PCR, you not only pick it up in the brain.",
    "start": "2775048",
    "end": "2780590"
  },
  {
    "text": "It shows up in the lung, in\nthe placenta, the thymus, and the lymph nodes.",
    "start": "2780590",
    "end": "2785869"
  },
  {
    "text": "It shows up in epithelial cells\nand CD4 positive lymphocytes, all tissues that\nhave been implicated",
    "start": "2785870",
    "end": "2791210"
  },
  {
    "text": "in the biology of asthma. So at least it's\nwhere it needs to be. Doesn't quite meet\nKoch's postulates yet.",
    "start": "2791210",
    "end": "2797250"
  },
  {
    "text": "But we're headed in\nthe right direction. For the third example, what\nI think I'll talk about",
    "start": "2797250",
    "end": "2804650"
  },
  {
    "text": "is a beta-agonist receptor. So what I've done so far is talk\nabout two association studies.",
    "start": "2804650",
    "end": "2810020"
  },
  {
    "text": "Clinical trials that were done. We then get the data\nand the DNA and we",
    "start": "2810020",
    "end": "2815090"
  },
  {
    "text": "do a bunch of genotyping\nand associations but it's all post hoc.",
    "start": "2815090",
    "end": "2821480"
  },
  {
    "text": "So now the story\nof beta agonists are slightly different. Beta-agonist inhalers are\nthe most commonly used asthma",
    "start": "2821480",
    "end": "2828080"
  },
  {
    "text": "treatment in the world. I don't know how many of\nyou read the New England Journal of Medicine. Have ever see the New\nEngland Journal of Medicine?",
    "start": "2828080",
    "end": "2834933"
  },
  {
    "text": "Nice graphics. [INAUDIBLE] lollipops\nin this picture. She's one of the\nartists that draws them.",
    "start": "2834933",
    "end": "2841410"
  },
  {
    "text": "And so that these inhalers\nare going off worldwide at the rate of about\n1,000 times a second.",
    "start": "2841410",
    "end": "2849840"
  },
  {
    "text": "So there's a lot\nof-- treat people using this kind of treatment. So in 1990, almost 15 years\nago, this fire was started.",
    "start": "2849840",
    "end": "2860390"
  },
  {
    "text": "A long-acting beta\nagonist came out. Now the problem\nwith those little inhalers-- they last\nthree or four hours.",
    "start": "2860390",
    "end": "2866910"
  },
  {
    "text": "So this drug company designed a\ndrug that can last and agonise at the receptor for 12 hours.",
    "start": "2866910",
    "end": "2874190"
  },
  {
    "text": "And the hypothesis was that if\nyou took it on a regular basis, your asthma would\nimprove because you'd be chronically dilated.",
    "start": "2874190",
    "end": "2881450"
  },
  {
    "text": "These drugs work by relaxing\nairway smooth muscle constricted in asthma.",
    "start": "2881450",
    "end": "2887040"
  },
  {
    "text": "So in this trial\ndesigned by the sponsors,",
    "start": "2887040",
    "end": "2892490"
  },
  {
    "text": "they were comparing this\nlong-acting beta-agonist with placebo. And it was a crossover design.",
    "start": "2892490",
    "end": "2897840"
  },
  {
    "text": "So half the patients\nstarted on formoterol, half started on placebo for\n26 weeks of treatment.",
    "start": "2897840",
    "end": "2903560"
  },
  {
    "text": "They got a month off. And then they were switch\nto the other treatment and followed for\nanother 26 weeks.",
    "start": "2903560",
    "end": "2910670"
  },
  {
    "text": "And in this trial,\nthe primary outcome was an asthma exacerbation. Rather than measuring\nlung function,",
    "start": "2910670",
    "end": "2917193"
  },
  {
    "text": "they said I'm going to wait\nfor your asthma get bad enough for you to be upset by it. And I'm going to click off\nthe asthma exacerbation",
    "start": "2917193",
    "end": "2924710"
  },
  {
    "text": "box when that happens. In the hypothesis had been that\nduring your final treatment,",
    "start": "2924710",
    "end": "2931099"
  },
  {
    "text": "you'd have fewer\nasthma exacerbations than during your placebo\ntreatment period. Because of the crossover design,\neverybody's in both arms.",
    "start": "2931100",
    "end": "2939680"
  },
  {
    "text": "So when these data\nwere published, the asthma world was surprised.",
    "start": "2939680",
    "end": "2944840"
  },
  {
    "text": "Because this is the number of\nsubjects without exacerbation with time. If treatment was 100% effective,\nyour line would go across here.",
    "start": "2944840",
    "end": "2954440"
  },
  {
    "text": "Every time a patient has\nan asthma exacerbation, the line kicks down. And the patient's then\ncensored from further analysis.",
    "start": "2954440",
    "end": "2961849"
  },
  {
    "text": "And you could see that\nthere for about a week or so they were the same. But then the patients that\ngot the regular treatment--",
    "start": "2961850",
    "end": "2969740"
  },
  {
    "text": "remember, the onset prevention\nwas worth a pound of cure. This is supposed to make\nyou better but actually having more asthma exacerbations\nat any given point in time",
    "start": "2969740",
    "end": "2978109"
  },
  {
    "text": "than the people who\nonly used beta-agonist when they needed it. And when these data\ncame out, there",
    "start": "2978110",
    "end": "2985730"
  },
  {
    "text": "was concern that actually\nthis very commonly used asthma treatment was causing harm.",
    "start": "2985730",
    "end": "2994339"
  },
  {
    "text": "And the fires were\nfueled by this paper that was published\nby my predecessors at the New England Journal.",
    "start": "2994340",
    "end": "3000380"
  },
  {
    "text": "I had nothing to do\nwith this, let you know. showing that the\nuse of beta-agonists",
    "start": "3000380",
    "end": "3006410"
  },
  {
    "text": "was associated with the\nrisk of death or near death through asthma. And what they did\nin this study is they went to this huge database,\nwhich is where every time you",
    "start": "3006410",
    "end": "3013820"
  },
  {
    "text": "get a prescription in the\nprovince of Saskatchewan, somebody knows who you are and\nwhat prescription you want.",
    "start": "3013820",
    "end": "3020480"
  },
  {
    "text": "And then they also matched that\nwith the asthma exacerbations, asthma death file when\npeople got really bad asthma.",
    "start": "3020480",
    "end": "3028670"
  },
  {
    "text": "Because they have\nhospital records. And they discovered\nthat the patients that used a lot of beta-agonist\neither died from their asthma",
    "start": "3028670",
    "end": "3037070"
  },
  {
    "text": "or were admitted to the hospital\nwith very severe asthma. And they concluded it\nwas cause and effect.",
    "start": "3037070",
    "end": "3044340"
  },
  {
    "text": "And they were totally wrong. This is a classic example\nof confounding by severity.",
    "start": "3044340",
    "end": "3050869"
  },
  {
    "text": "Or more simply put,\nthe sicker patients were using their\nbeta inhalers a lot. And they're the ones that are\nmore likely to die from asthma.",
    "start": "3050870",
    "end": "3058980"
  },
  {
    "text": "So it was bad epidemiology. But while we were\nworking that out,",
    "start": "3058980",
    "end": "3064400"
  },
  {
    "text": "this trial was\nconceived by the people at the NIH, who became\nconcerned that a common asthma",
    "start": "3064400",
    "end": "3070010"
  },
  {
    "text": "medicine was making you sick. And so we put\ntogether this trial called the beta-agonist study.",
    "start": "3070010",
    "end": "3076819"
  },
  {
    "text": "All clinical trials\nhave to have a name. Otherwise, you\nwould have to say, remember that trial where\nthey compared drug X to drug Y",
    "start": "3076820",
    "end": "3083480"
  },
  {
    "text": "in a 24-week crossover\ndesign trial. It was published in The Lancet.",
    "start": "3083480",
    "end": "3089630"
  },
  {
    "text": "remember the bags trial\nor something like that. So all good clinical\ntrials have a name. This was the bags trial.",
    "start": "3089630",
    "end": "3096180"
  },
  {
    "text": "And in this trial\nwe enrolled patients with really mild asthma for\na six-week run-in period when they were on their\nstandard treatment.",
    "start": "3096180",
    "end": "3103220"
  },
  {
    "text": "And then they were randomized to\nreceive either albuterol, which is a short-acting beta inhaler.",
    "start": "3103220",
    "end": "3108619"
  },
  {
    "text": "So you take it four times a day. This is the one that's used\nso often around the world.",
    "start": "3108620",
    "end": "3115280"
  },
  {
    "text": "And they were given\na coated inhaler. It was white. And it said, study drug. Take two puffs four times a day.",
    "start": "3115280",
    "end": "3122360"
  },
  {
    "text": "And I've already told you about\nfour times a day medication. So this inhaler had\nin it a computer chip.",
    "start": "3122360",
    "end": "3128390"
  },
  {
    "text": "And the patients knew this. Every time they\npressed the inhaler, it recorded the time\nof day and the date.",
    "start": "3128390",
    "end": "3134960"
  },
  {
    "text": "And we knew that\nwe had about 95% compliance, at least with\npressing the inhaler.",
    "start": "3134960",
    "end": "3140510"
  },
  {
    "text": "There wasn't a video camera\nin the computer chip. I don't know whether the\npatient actually inhaled when they pressed the inhaler.",
    "start": "3140510",
    "end": "3146720"
  },
  {
    "text": "But we think that\npressing the inhaler meant that they\nactually used it.",
    "start": "3146720",
    "end": "3152328"
  },
  {
    "text": "And that was a coating inhaler. And they were also given\nan open-label albuterol. And said, if your asthma\nis still acting up,",
    "start": "3152328",
    "end": "3158870"
  },
  {
    "text": "you can take this. And so all the patients\nwere given that. The placebo group was\ngiven an identical inhaler,",
    "start": "3158870",
    "end": "3166910"
  },
  {
    "text": "identical instructions,\nidentical computer chip, and open-label albuterol. And the hypothesis was that\nif regular use of beta-agonist",
    "start": "3166910",
    "end": "3175309"
  },
  {
    "text": "was bad for you, that the\nblue group would do poorly compared to the green group. Now rather than powering the\nstudy for asthma exacerbations,",
    "start": "3175310",
    "end": "3183230"
  },
  {
    "text": "because in these very\nmild asthma patients, you were taking 1,000\npatients studied for a year.",
    "start": "3183230",
    "end": "3189470"
  },
  {
    "text": "We used a surrogate\nendpoint, which was lung function,\nstrongly related to how patients do with\nasthma, taken over 16 weeks.",
    "start": "3189470",
    "end": "3203340"
  },
  {
    "text": "And here the data which\nwe published actually in the New England Journal\nof Medicine in '96.",
    "start": "3203340",
    "end": "3209630"
  },
  {
    "text": "It showed that the\nmorning peak, which is our primary\noutcome, the two groups",
    "start": "3209630",
    "end": "3216260"
  },
  {
    "text": "were not statistically\ndistinguishable. Here, it's a very\nexpanded scale. And the difference between these\ntwo and 15 liters per minute",
    "start": "3216260",
    "end": "3222920"
  },
  {
    "text": "is probably not significant. We had gone in saying that\nthis difference, 25, was",
    "start": "3222920",
    "end": "3228920"
  },
  {
    "text": "significant. And it got only halfway there. But interestingly,\nthe blue group",
    "start": "3228920",
    "end": "3234530"
  },
  {
    "text": "did a little poorer\nthan the green group, even though the\ndifference wasn't statistically significant. This wasn't a sign of these\ntreatments being worse for you.",
    "start": "3234530",
    "end": "3242840"
  },
  {
    "text": "But we concluded that they\nweren't worse for you. In fact, we looked at\na bunch of outcomes. Now while we were doing this\ntrial, while data accrual was",
    "start": "3242840",
    "end": "3250760"
  },
  {
    "text": "going on-- this is the beta-2\nadrenergic receptor-- a number of polymorphisms\nwere identified in it.",
    "start": "3250760",
    "end": "3258680"
  },
  {
    "text": "Now these two, which\nare right up here near the n-terminal\npart of the receptor,",
    "start": "3258680",
    "end": "3264050"
  },
  {
    "text": "have very high\nallele frequencies. The minor allele frequencies\nare on the order of 0.4,",
    "start": "3264050",
    "end": "3269224"
  },
  {
    "text": "and they're very common. And we knew from\nthe work of others that these were functional. That is that an [? RH16 ?]\nreceptor behaved differently",
    "start": "3269225",
    "end": "3277250"
  },
  {
    "text": "than a [? glycine ?] receptor. We also knew that\nRH16 was in very",
    "start": "3277250",
    "end": "3282260"
  },
  {
    "text": "strong linkage disequilibrium\nwith [? Glyn ?] 27. So that if you were RH16,\nyou were likely Glenn 27.",
    "start": "3282260",
    "end": "3290420"
  },
  {
    "text": "So what we did was we\nstratified the data from that clinical trial based\non these genotypes, again,",
    "start": "3290420",
    "end": "3298369"
  },
  {
    "text": "a retrospective analysis. And here are the findings. If you had the Gly/Gly\ngenotype and used beta-agonist",
    "start": "3298370",
    "end": "3307789"
  },
  {
    "text": "on a regular basis,\nyour morning peak flow after treatment oscillates\naround the zero line.",
    "start": "3307790",
    "end": "3316070"
  },
  {
    "text": "If you have the Arg/Arg genotype\nand only used beta-agonist when you needed it, which\nworks out to be about a puff",
    "start": "3316070",
    "end": "3322880"
  },
  {
    "text": "every other day,\nnothing happened. But if you have the\nArg/Arg genotype",
    "start": "3322880",
    "end": "3329900"
  },
  {
    "text": "and are using two\npuffs four times a day, there's a fall in peak\nflow during and after",
    "start": "3329900",
    "end": "3336050"
  },
  {
    "text": "the active treatment\nperiod, suggesting that it's not that the\ndrugs don't work anymore.",
    "start": "3336050",
    "end": "3343020"
  },
  {
    "text": "In fact, when you take them\nyou get bronchodilation. But there's a side effect. ",
    "start": "3343020",
    "end": "3350240"
  },
  {
    "text": "When the drug wears\noff, you're worse than you were before\nyou started taking it.",
    "start": "3350240",
    "end": "3357272"
  },
  {
    "text": "And that's what\nthis is showing us. Because this is the morning\npeak flow before treatment.",
    "start": "3357272",
    "end": "3362280"
  },
  {
    "text": "So this says that using\na drug on a regular basis makes you worse in the\nmorning than you would",
    "start": "3362280",
    "end": "3367610"
  },
  {
    "text": "be if you hadn't used the drug. But it's genotype related. ",
    "start": "3367610",
    "end": "3373860"
  },
  {
    "text": "So that led us to do\na perspective trial. And so this is like the gold\nstandard in this business.",
    "start": "3373860",
    "end": "3380930"
  },
  {
    "text": "Rather than sifting\nthrough all data, you start off with\nnew data that were designed by BARG\ntrial, beta-agonist",
    "start": "3380930",
    "end": "3389119"
  },
  {
    "text": "receptor by genotype. And this was two\nidentical trials",
    "start": "3389120",
    "end": "3395510"
  },
  {
    "text": "in which patients were enrolled\nwith the Arg/Arg genotype. A matching Gly/Gly\ngenotype patient",
    "start": "3395510",
    "end": "3402770"
  },
  {
    "text": "was found, at least with respect\nto sex and lung function. And then both groups of patients\nwere put in this design.",
    "start": "3402770",
    "end": "3412250"
  },
  {
    "text": "And the idea was that\nin the Arg/Arg patients, we were expecting that placebo\nwould be superior to albuterol.",
    "start": "3412250",
    "end": "3421700"
  },
  {
    "text": "Because we think that these are\nthe patients where albuterol given regularly has\na detrimental effect.",
    "start": "3421700",
    "end": "3428150"
  },
  {
    "text": "While in the Gly/Gly\npatients, this difference would not exist.",
    "start": "3428150",
    "end": "3434430"
  },
  {
    "text": "And then if we\nthen did a genotype by treatment interaction--",
    "start": "3434430",
    "end": "3439980"
  },
  {
    "text": "we would say that if you look\nat Gly/Gly on active treatment versus Arg/Arg on\nactive treatment,",
    "start": "3439980",
    "end": "3445849"
  },
  {
    "text": "that these patients\nwould be better, these patients would\nbe worse, and there'd be a big difference\nbetween the two groups.",
    "start": "3445850",
    "end": "3452880"
  },
  {
    "text": "And that's how we designed it. Our primary outcome\nvariable, again, was a measurement of lung\nfunction, morning peak flow,",
    "start": "3452880",
    "end": "3459920"
  },
  {
    "text": "with these secondary outcomes.  So we enrolled 332 patients\nwith that genotype.",
    "start": "3459920",
    "end": "3468930"
  },
  {
    "text": "78 met the criteria. And so this is an\ninteresting trial. Because as far as I know,\nit's the first trial",
    "start": "3468930",
    "end": "3476130"
  },
  {
    "text": "where people were\nenrolled by genotype in a non-malignant condition.",
    "start": "3476130",
    "end": "3481770"
  },
  {
    "text": "They came in and they met\nclinical and physiological criteria. They say, you're a\npatient for our trial.",
    "start": "3481770",
    "end": "3487290"
  },
  {
    "text": "Now let's genotype you. Because we knew that one out\nof six people was in Arg/Arg.",
    "start": "3487290",
    "end": "3493470"
  },
  {
    "text": "If you were then met the\ncriteria and were in Arg/Arg, you were enrolled in the trial.",
    "start": "3493470",
    "end": "3499079"
  },
  {
    "text": "We then went through the people\nwho we determined to be Gly/Gly and looked for a match, sex,\nlung function, and center",
    "start": "3499080",
    "end": "3506760"
  },
  {
    "text": "where they were studying. So we ended up\nwith these people.",
    "start": "3506760",
    "end": "3513565"
  },
  {
    "text": "These were the baseline\ncharacteristics of the two groups. We matched on sex. And we came as\nclose as you could.",
    "start": "3513565",
    "end": "3521040"
  },
  {
    "text": "In terms of the proportions\nthat were Caucasian, they worked out to\nbe about the same.",
    "start": "3521040",
    "end": "3526950"
  },
  {
    "text": "Their ages worked\nout to be the same. Their lung functions\nworked out to be the same. So we had two reasonably\nmatched groups",
    "start": "3526950",
    "end": "3532920"
  },
  {
    "text": "of people that differed with\nrespect to their genotype at the beta-2\nadrenergic receptor.",
    "start": "3532920",
    "end": "3540070"
  },
  {
    "text": "So this was unexpected. What happened in this\ntrial was different",
    "start": "3540070",
    "end": "3545789"
  },
  {
    "text": "from our other trials. We had the patients\non beta agonist",
    "start": "3545790",
    "end": "3554070"
  },
  {
    "text": "on a regularly schedule basis. But they had a\nbeta-agonist inhaler they were using if\ntheir asthma acted up.",
    "start": "3554070",
    "end": "3560640"
  },
  {
    "text": "So when we did this trial, we\nswitched their rescue inhaler from a beta-agonist\ninhaler to another type",
    "start": "3560640",
    "end": "3568109"
  },
  {
    "text": "of rescue inhaler called\nAtrovent, an ipratropium bromide, which doesn't\nwork at this receptor.",
    "start": "3568110",
    "end": "3574380"
  },
  {
    "text": "And we allowed six\nweeks for patients to get used to using\nthat treatment.",
    "start": "3574380",
    "end": "3579480"
  },
  {
    "text": "Well, we hadn't\nexpected this to happen. But what happened was\nin the Gly/Gly patients,",
    "start": "3579480",
    "end": "3585330"
  },
  {
    "text": "their peak flow stayed fixed. Well, in the\nArg/Arg patients who were using their albuterol\nfour or five times a day,",
    "start": "3585330",
    "end": "3595350"
  },
  {
    "text": "just kind of in regular\nuse, when we switched them to ipratropium bromide\nover six weeks,",
    "start": "3595350",
    "end": "3600630"
  },
  {
    "text": "it improved their lung\nfunction 30 liters a minute, actually 28 liters a minute.",
    "start": "3600630",
    "end": "3606150"
  },
  {
    "text": "Now that's as good as you\nget out of most treatments you pay money for it. And all we did was switch\nthem from albuterol",
    "start": "3606150",
    "end": "3614280"
  },
  {
    "text": "to ipratropium bromide. But in our trial design,\nwe said the zero point",
    "start": "3614280",
    "end": "3619350"
  },
  {
    "text": "is going to be six weeks. So all our comparisons\nare made from here, where we had this big effect\nduring the run-in, which",
    "start": "3619350",
    "end": "3628140"
  },
  {
    "text": "we hadn't counted on. Then during the trial--",
    "start": "3628140",
    "end": "3633190"
  },
  {
    "text": "so the Arg/Arg is yellow. The Gly/Gly is blue-- They start off with peak\nflows of around 470.",
    "start": "3633190",
    "end": "3640349"
  },
  {
    "text": "The Arg/Args get worse\non active treatment while the Gly/Glys get better.",
    "start": "3640350",
    "end": "3645720"
  },
  {
    "text": "While on placebo, the\nArg/Args get better and the Gly/Glys get worse.",
    "start": "3645720",
    "end": "3651670"
  },
  {
    "text": "This is the primary\noutcome peak flow. When we express it this way-- this is now morning peak flow.",
    "start": "3651670",
    "end": "3658680"
  },
  {
    "text": "And so each of these bars\nrepresents a difference between active and placebo.",
    "start": "3658680",
    "end": "3664510"
  },
  {
    "text": "So if active is worse\nthan placebo, you go down. And if active is better\nthan placebo, you go up.",
    "start": "3664510",
    "end": "3671490"
  },
  {
    "text": "Arg is red. Gly is green. And you see that the\ndifference between the two,",
    "start": "3671490",
    "end": "3677250"
  },
  {
    "text": "highly statistically\nsignificant, with a value that's on the\norder of 23 liters per minute.",
    "start": "3677250",
    "end": "3683760"
  },
  {
    "text": "We said 25 would have been\nclinically significant. It came close but\ndidn't hit that bar.",
    "start": "3683760",
    "end": "3691920"
  },
  {
    "text": "Then at evening peak\nflow, the difference is also in the same sign. But interestingly, there have\nbeen some recovery of lung",
    "start": "3691920",
    "end": "3699060"
  },
  {
    "text": "function during the day. And our other outcomes. FEV1-- and difference\nagain in the same sign.",
    "start": "3699060",
    "end": "3707460"
  },
  {
    "text": "Arg/Args get worse. Gly/Glys get better. The difference is about\n150 liters per minute.",
    "start": "3707460",
    "end": "3712710"
  },
  {
    "text": "Everybody agrees this is\nstatistically significant. When we look at symptoms. And here, a bigger\nnumber is more symptoms.",
    "start": "3712710",
    "end": "3719835"
  },
  {
    "text": "There are more symptoms\nwhen the patients are using the drug on\na regular basis than they are when\nthey're using placebo.",
    "start": "3719835",
    "end": "3725710"
  },
  {
    "text": "Again, in a sign\nof Gly/Glys doing better on active\nand Arg/Args doing worse on active treatment,\nso highly likely",
    "start": "3725710",
    "end": "3733980"
  },
  {
    "text": "not to have occurred by chance. Now my final outcome here\nis how often the patients",
    "start": "3733980",
    "end": "3739680"
  },
  {
    "text": "had to use a rescue inhaler. The ipratropium bromide was\nthe non-beta-agonist rescue",
    "start": "3739680",
    "end": "3746070"
  },
  {
    "text": "inhaler. Albuterol is a beta-agonist\nrescue inhaler. And we found the same thing.",
    "start": "3746070",
    "end": "3751920"
  },
  {
    "text": "Remember, during this\nperiod, the patients are getting albuterol\neight puffs a day already.",
    "start": "3751920",
    "end": "3758790"
  },
  {
    "text": "And they're taking more of it. It's not enough. ",
    "start": "3758790",
    "end": "3764760"
  },
  {
    "text": "When the Gly/Glys are\nusing at eight puffs a day, they cut back on\ntheir daily use.",
    "start": "3764760",
    "end": "3769900"
  },
  {
    "text": "So the difference between these\ngroups-- three puffs a day is highly significant. And in the sign that we're\nmaking the Arg/Arg patients",
    "start": "3769900",
    "end": "3778530"
  },
  {
    "text": "worse with active treatment. So I think the clue out of\nthis one is that about 1/6",
    "start": "3778530",
    "end": "3785760"
  },
  {
    "text": "out of patients with\nasthma in the US are probably being made worse\nby their albuterol treatment,",
    "start": "3785760",
    "end": "3792460"
  },
  {
    "text": "which is actually a very\ncommonly used asthma therapy. Now this study was not calling\nfor asthma exacerbations.",
    "start": "3792460",
    "end": "3800670"
  },
  {
    "text": "To do that, we would\nhave had to study, as I said, about 1,000\npeople for a year.",
    "start": "3800670",
    "end": "3807240"
  },
  {
    "text": "And to study 1,000\npeople, you would've had to screen 3,000 or\nmaybe more like 4,000,",
    "start": "3807240",
    "end": "3814320"
  },
  {
    "text": "because it's going to\nbe genotype stratified. But these two things track. And those kinds of trials\nare under consideration",
    "start": "3814320",
    "end": "3822000"
  },
  {
    "text": "but are not completed yet. So I've given you\nthree examples--",
    "start": "3822000",
    "end": "3827400"
  },
  {
    "text": "antileukotrienes where\nwe've shown an effect based on what we know about the\nbiology of the pathway but one",
    "start": "3827400",
    "end": "3834299"
  },
  {
    "text": "of little pharmacoeconomic\nconsequences, inhaled steroids\nwhere we weren't",
    "start": "3834300",
    "end": "3839340"
  },
  {
    "text": "quite able to replicate\nfinding [? three ?] genes. Well, we have a gene\nbut probably not a SNP",
    "start": "3839340",
    "end": "3847710"
  },
  {
    "text": "related to the steroid response. It'd also useful to try to\ndo a controlled perspective",
    "start": "3847710",
    "end": "3853440"
  },
  {
    "text": "trial that way. And then with the\nbeta agonist, we've done the controlled\nperspective trial",
    "start": "3853440",
    "end": "3859619"
  },
  {
    "text": "showing the genotype makes\na difference in treatment response. So that it's more\nthan just an idea,",
    "start": "3859620",
    "end": "3866680"
  },
  {
    "text": "it's something we can\nactually reduce to practice. And so these are three\nexamples in asthma treatment",
    "start": "3866680",
    "end": "3873730"
  },
  {
    "text": "which tested the advantage\nof being a recurrent disease requiring chronic therapy.",
    "start": "3873730",
    "end": "3878820"
  },
  {
    "text": "And if I were\ndoing a trial where I wasn't allowed to take\npatients off treatment,",
    "start": "3878820",
    "end": "3887980"
  },
  {
    "text": "right where the\noutcomes are going to be strokes, or heart,\nattacks or terrible events, then",
    "start": "3887980",
    "end": "3893700"
  },
  {
    "text": "you'd be-- not have\nthis kind of freedom. Even when you're using blood\npressure as an outcome. You don't want to let someone's\nblood pressure go uncontrolled.",
    "start": "3893700",
    "end": "3901275"
  },
  {
    "text": "But here, you can really\nshow a genotype by treatment interaction different\nkinds of ways.",
    "start": "3901275",
    "end": "3906869"
  },
  {
    "text": "And you can expand this to\nother kinds of diseases, doing the right kinds\nof treatment trials where you begin to enroll people\nby genotype and informative",
    "start": "3906870",
    "end": "3916440"
  },
  {
    "text": "genotypes, which you find out\nfrom the evaluation of all data",
    "start": "3916440",
    "end": "3922589"
  },
  {
    "text": "to decide whether this\nmakes sense to move forward. So this is where\nI see, to me, one",
    "start": "3922590",
    "end": "3929520"
  },
  {
    "text": "of the major advantages of\ngenetics in actual medicine",
    "start": "3929520",
    "end": "3935190"
  },
  {
    "text": "years. I mean, I can find the\ngenes that cause things. But all I can do is give\nyou bad or good news.",
    "start": "3935190",
    "end": "3941339"
  },
  {
    "text": "You don't have a gene\nfor Huntington's disease. You don't have the gene for\nParkinson's disease or you do.",
    "start": "3941340",
    "end": "3947082"
  },
  {
    "text": "Now you're going\nto worry about it, but you can't do\nanything about it. I might be able to\ntell you, you have",
    "start": "3947082",
    "end": "3952760"
  },
  {
    "text": "a gene for a form of emphysema. And you shouldn't smoke.",
    "start": "3952760",
    "end": "3958530"
  },
  {
    "text": "But still, there's very\nlittle the information that I can do with the\ninformation about a gene that I harbor or don't harbor,\nother than making decisions",
    "start": "3958530",
    "end": "3966150"
  },
  {
    "text": "about my kids, and when\nI want to have kids, and who I want to marry.",
    "start": "3966150",
    "end": "3972359"
  },
  {
    "text": "And it's interesting, in some\nregions of New York City where",
    "start": "3972360",
    "end": "3977460"
  },
  {
    "text": "they have these arranged\nAshkenazi Jewish marriages, they have a number\nof genetic diseases.",
    "start": "3977460",
    "end": "3983130"
  },
  {
    "text": "They're actually\ngenotyping the people in the arranged marriages\nso that they don't end up",
    "start": "3983130",
    "end": "3989730"
  },
  {
    "text": "with Tay-Sachs disease and\nother commonly inherited--",
    "start": "3989730",
    "end": "3994740"
  },
  {
    "text": "but they're arranged marriages. A lot of marriages these\ndays aren't arranged.",
    "start": "3994740",
    "end": "4000560"
  },
  {
    "text": "So it's not terribly\nuseful information. If on the other hand\nyou have a disease, and I can look at your genotype\nand modify my treatment so that",
    "start": "4000560",
    "end": "4010430"
  },
  {
    "text": "in one case, you're\nlikely to get better. In another case,\nI know that a drug isn't going to work for you.",
    "start": "4010430",
    "end": "4015650"
  },
  {
    "text": "That's a much more medically\nuseful thing to know. I'm sorry that you\ninherited these genes that",
    "start": "4015650",
    "end": "4022070"
  },
  {
    "text": "are going to cause you\nto have this bad disease. But at least I know from\nyour genetic profile",
    "start": "4022070",
    "end": "4027080"
  },
  {
    "text": "what treatment you're more\nlikely to respond to it. And so that's why I think--",
    "start": "4027080",
    "end": "4033470"
  },
  {
    "text": "what is going to make a\ndifference in genetics and medicine? This is going to\nmake a difference. And we're seeing it\nnow with leukemias.",
    "start": "4033470",
    "end": "4041840"
  },
  {
    "text": "We're going through and\ndoing these studies looking at patients that have a\ncertain kind of leukemia who",
    "start": "4041840",
    "end": "4046910"
  },
  {
    "text": "are likely to have a\ngood treatment response and who aren't likely to have\na good treatment response.",
    "start": "4046910",
    "end": "4052425"
  },
  {
    "text": "What that means\nis that if you're sure in the good\ntreatment response group, I can treat your leukemia\nand maybe not come",
    "start": "4052425",
    "end": "4059810"
  },
  {
    "text": "so close to killing them. While if you're in a bad\ntreatment response group, I'm going to get out everything\nI possibly can from day zero.",
    "start": "4059810",
    "end": "4067630"
  },
  {
    "text": "And I'm going to try\nto wipe out every cell. So that I think\nthis is much more medically useful than\nfinding causative genes.",
    "start": "4067630",
    "end": "4075760"
  },
  {
    "text": "We have to find genes that\nhelp us modify and understand our treatment response. So that's my story.",
    "start": "4075760",
    "end": "4083500"
  },
  {
    "start": "4083500",
    "end": "4084000"
  }
]